AFT grows share price with US market approval

+News

AFT grows share price with US market approval

Jonathan
Chilton-Towle
Founder of AFT Pharmaceuticals
AFT managing director Hartley Atkinson [Image: Supplied]
The New Zealand share market has reacted positively to the news that AFT Pharmaceuticals’ flagship product Maxigesic was approved for sale in the US.